New study reveals link between aspirin use, Type 2 diabetes
NEW YORK The results of a study published in the American Journal of Medicine suggest there may be an association between aspirin use and a decreased risk of developing Type 2 diabetes.
To investigate, researchers from University Graduate School of Medicine, Kyoto, Japan, analyzed data from the Physician’s Health Study, which includes 22,071 seemingly healthy male participants, and has accumulated 22 years of follow-up data.
The participants provide self reports of history of diabetes, aspirin use and various lifestyle factors at study entry and in yearly follow-up questionnaires.
A total of 1,719 cases of diabetes were reported during follow-up. The men who reported taking any aspirin were 14% less likely to develop diabetes, compared with those who did not take aspirin.
Non-aspirin, non-steroidal anti-inflammatory drugs were not associated with a decreased risk of developing diabetes.
“Decreased risk of Type 2 diabetes may be added to the list of clinical benefits of aspirin,” researchers concluded. “Future studies are warranted to further investigate this association.”
Generex subsidiary, Immune Tolerance Network to develop improved diabetes diagnostic test
WORCESTER, Mass. The Immune Tolerance Network and a company that develops immunotherapeutics have signed an agreement to implement a better diagnostic test for Type 1 diabetes.
Antigen Express, a subsidiary of Generex Biotechnology Corp., said Tuesday that the diagnostic test is based on technology that Antigen Express is developing and that the ability to identify patients with Type 1 diabetes earlier and more accurately would benefit the management of those patients.
Antigen Express’s technology allows for more potent and specific activation of CD4+ T helper cells, both after immunization and using blood cells outside the body. In Type 1 diabetes, also known as juvenile-onset diabetes, the cells become aberrantly activated to recognize proteins associated with cells involved in insulin secretion, leading to the cells’ destruction.
Viactiv partners with Susan G. Komen for the Cure, continuing its ‘Style and Strength for Life’ Campaign
NEW YORK A calcium supplement brand has become a sponsor of Susan G. Komen for the Cure, the world’s largest breast cancer organization.
Viactiv Calcium Soft Chews, which contain 125% of the daily value of vitamin D, pledged a sponsorship of $100,000 between August 2008 and July 2009. The brand’s sponsorship is part of the year-long “Style and Strength for Life” campaign, which is built on an innovative platform uniting the Viactiv brand with breakout fashion designer Ashleigh Verrier and her mother and business partner Jude Verrier. The initiative was established to educate women about the connection between adequate calcium, essential vitamins (particularly vitamin D) and healthy beauty.
As part of its “Style and Strength for Life” campaign, and serving as the cornerstone of its Susan G. Komen for the Cure partnership, the Viactiv will also appear as one of the “silver-level” sponsors of the Komen Philadelphia Race for the Cure this May. The race will take place on May 10 at 8:15 a.m. at Eakins Oval at the Philadelphia Art Museum. The brand, along with Ashleigh and Jude Verrier, will inspire walkers to pledge their “daily promise to be strong.” Each promise, written on a special hangtag, will come together to create a powerful display of strength.
Additionally, limited-edition “My Daily Promise” bracelets, designed by Ashleigh Verrier, will be awarded to participants and spectators via a random drawing during the race. Consumers will also have the opportunity to enter an online contest in May at www.viactiv.com for their chance to win a limited-edition bracelet. The “My Daily Promise” bracelet, a ring of silver beads and one standout bead encrusted with brilliant purple Swarovski crystals accompanied by a chic “V” charm, was developed earlier this year — and gifted to various celebrities during Mercedes-Benz Fashion Week — to bring the message of healthy beauty to life. The “My Daily Promise” bracelet serves as a stylish reminder to take Viactiv Calcium supplements each day as a commitment to healthy beauty and wellness.